Search results
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 1 day agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds
Prevention· 5 days agoBased on recent findings, Eli Lilly plans to submit the material to the U.S. Food and Drug ...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WKMG ClickOrlando· 14 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
WTAE Pittsburgh· 7 days agoAbout 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy,...
Barbra Streisand explains Melissa McCarthy Ozempic comment: 'Forgot the world is reading'
USA TODAY via Yahoo News· 10 hours agoIn June 2021, the Food and Drug Administration approved the semaglutide – under the brand name...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 2 days agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
Investing.com· 21 hours agoLilly said it expects significant production increases in the second half of the year for its ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 16 hours agoNow, Lilly is planning to ask the Food and Drug Administration to sign off on tirzepatide as a sleep...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 6 days ago"As important as these drugs...potential to bankrupt Medicare, Medicaid and our entire health care...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 22 hours agoDive Insight: The obesity drug boom has made Lilly the most valuable pharmaceutical company in the...